ArticleDrug design, development and therapy2026
Preclinical Assessment of HLA-A*02:01-Restricted PSMA and STEAP1 Epitopes for Peptide-Based Immunotherapy in Prostate Cancer.
Yueting Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.